COVID-19 vaccines
Marketing authorisation
application submitted
No marketing authorisation applications currently under evaluation
Potential COVID-19 vaccines under investigation whose developers have received EMA advice. | Potential COVID-19 vaccines currently undergoing evaluation by EMA. |
COVID-19 vaccines authorised for use in the EU, following evaluation by EMA, with links to detailed information on each authorised vaccine. | COVID-19 vaccines: Article 5(3) reviews COVID-19 vaccines reviewed for use in the EU under Article 5(3) of Regulation 726/2004. |
Key facts about COVID-19 vaccines in the EU. | COVID-19 vaccines: development, evaluation, approval and monitoring Detailed information on the development, evaluation, approval and monitoring of COVID-19 vaccines in the EU. |
COVID-19 vaccines: studies for approval Detailed information on the studies EMA requires to confirm a vaccine is safe, provides adequate protection and is of suitable quality. |
|